Dr Cyndi J Mccormick, DO | |
201 S Market St, Ottumwa, IA 52501-2924 | |
(641) 683-5773 | |
(641) 226-5759 |
Full Name | Dr Cyndi J Mccormick |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 201 S Market St, Ottumwa, Iowa |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356754337 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | DO-04822 (Iowa) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Cyndi J Mccormick, DO 201 S Market St, Ottumwa, IA 52501-2924 Ph: () - | Dr Cyndi J Mccormick, DO 201 S Market St, Ottumwa, IA 52501-2924 Ph: (641) 683-5773 |
News Archive
Since the 1980s, the physical and mental health of Swedish children and young people has been measured by way of surveys. One of these is the international "Health Behavior in School-aged Children Survey" (HBSC), which is taken by 11-, 13- and 15-year-olds every fourth year during a class in school.
Whether on a battlefield, in a factory or at a rock concert, noise-induced hearing loss is one of the most common hazards people face. Researchers at Washington University School of Medicine in St. Louis have identified a low-dose, two-drug cocktail that reduces hearing loss in mice when given before they are exposed to loud noise. The drugs, already FDA-approved for other conditions, also treat hearing loss after noise exposure.
Research led by Dr. Vladimir Hachinski of The University of Western Ontario reveals just how important it is for patients to be referred to a stroke prevention clinic following either a mild stroke or a transient ischemic attack (TIA). The study, published in the journal Stroke in November, showed a 26% reduction in one-year mortality rates among those referred to a stroke prevention clinic.
Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine technology company, and subsidiary of Emmaus Life Sciences, Inc., today announced that the European Commission (EC) has granted Orphan Medicinal Product designation for the company's investigational drug Levoglutamide (L-glutamine) for the treatment of sickle cell disease.
InterMune, Inc. today announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the European Union (EU). Currently, there are no EMA-approved treatments for IPF in the EU.
› Verified 5 days ago
Jimmy R. Mascaro, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 312 E Alta Vista Ave, Ottumwa, IA 52501 Phone: 641-683-4454 Fax: 641-683-4450 | |
Quentin Stokes Dickins Jr., M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1112 N Van Buren Ave, Suite 3, Ottumwa, IA 52501 Phone: 641-682-8302 Fax: 641-682-6534 | |
Marc E Hines, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1313 N Court St, Suite B, Ottumwa, IA 52501 Phone: 641-682-4978 Fax: 641-682-0722 | |
Dr. Taniya Pradhan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1001 Pennsylvania Ave, Ottumwa, IA 52501 Phone: 641-684-2300 | |
Dr. Joseph Hime Iii, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1001 Pennsylvania Ave, Ottumwa, IA 52501 Phone: 641-682-7511 | |
Dr. Ronald Ray Berges, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1112 N Van Buren Ave, Ottumwa, IA 52501 Phone: 641-684-7744 |